Literature DB >> 21739758

Implementation of the biosimilar pathway: economic and policy issues.

Henry Grabowski1, Genia Long, Richard Mortimer.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21739758

Source DB:  PubMed          Journal:  Seton Hall Law Rev        ISSN: 0586-5964


× No keyword cloud information.
  2 in total

1.  Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience.

Authors:  François Bocquet; Anaïs Loubière; Isabelle Fusier; Anne-Laure Cordonnier; Pascal Paubel
Journal:  Pharmacoeconomics       Date:  2016-11       Impact factor: 4.981

Review 2.  Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?

Authors:  María-Isabel Farfan-Portet; Sophie Gerkens; Isabelle Lepage-Nefkens; Irmgard Vinck; Frank Hulstaert
Journal:  Eur J Health Econ       Date:  2013-11-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.